SCHEMBL30254040

SCHEMBL30254040

NC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GRPR P30550 3/20 0.51
▸ OPRD1 P41143 3/20 0.49
▸ OPRM1 P35372 2/20 0.49
▸ PRMT1 Q99873 1/20 0.48
▸ CCKBR P32239 7/20 0.47
▸ CCKAR P32238 2/20 0.47
▸ GLP1R P43220 2/20 0.46
▸ KISS1R Q969F8 1/20 0.46
▸ ERAP2 Q6P179 1/20 0.45
▸ CTSL P07711 1/20 0.45
▸ CTSH P09668 1/20 0.45
▸ CTSS P25774 1/20 0.45
▸ CTSK P43235 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30254236 1.00 GRPR (0.51) GRPROPRD1OPRM1PRMT1CCKBR
SCHEMBL30254250 0.94 ACE (0.50) ERAP2
SCHEMBL31721034 0.90 GHSR (0.54) ERAP2
SCHEMBL30506405 0.90 GHSR (0.54) GRPRERAP2
SCHEMBL30518108 0.88 GHSR (0.52) OPRD1OPRM1PRMT1
SCHEMBL29973876 0.88 ACE (0.57) —
SCHEMBL29577528 0.88 ACE (0.57) —
SCHEMBL31259938 0.88 ACE (0.57) —
SCHEMBL31259940 0.88 ACE (0.57) —
SCHEMBL30628987 0.88 ACE (0.57) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3720873-B1 GLUCAGON-LIKE PEPTIDES IP2IPO INNOVATIONS LTD (GB) 2024-12-04 — — EP claimed
US-11591380-B2 Glucagon-like peptides IP2IPO INNOVATIONS LIMITED (GB) 2023-02-28 — — US claimed
US-11591380-B2 Glucagon-like peptides IP2IPO INNOVATIONS LIMITED (GB) 2023-02-28 — — US disclosed
Send feedback